Cargando…

miR-187-3p increases gemcitabine sensitivity in breast cancer cells by targeting FGF9 expression

Breast cancer is the most common type of malignancy in women, which remains a significant health concern worldwide. Gemcitabine is a frequently applied anticancer pharmacological agent. However, the efficacy of gemcitabine is limited by chemoresistance. In the present study, a combination of reverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yingqi, Tao, Li, Liang, Junwei, Qiao, Yashun, Liu, Weiwei, Yu, Haina, Yu, Xinghui, Liu, Lanfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388565/ https://www.ncbi.nlm.nih.gov/pubmed/32765654 http://dx.doi.org/10.3892/etm.2020.8770

Ejemplares similares

miR-187 inhibits the growth of cervical cancer cells by targeting FGF9
por: Liang, Hua, et al.
Publicado: (2017)

[Retracted] miR‑187 inhibits the growth of cervical cancer cells by targeting FGF9
por: Liang, Hua, et al.
Publicado: (2023)

MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9
por: Liang, Zhihua, et al.
Publicado: (2019)

Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor
por: Lin, Shu-Chun, et al.
Publicado: (2016)

miR-187/PDLIM1 Gets Involved in Gastric Cancer Progression and Cisplatin Sensitivity of Cisplatin by Mediating the Hippo-YAP Signaling Pathway
por: Tan, Yeru, et al.
Publicado: (2022)

Effect of lentivirus-mediated miR-182 targeting FGF9 on hallux valgus
por: Zhang, Wei-Lin, et al.
Publicado: (2021)

miR-187 inhibits tumor growth and invasion by directly targeting MAPK12 in osteosarcoma
por: Cui, Chengliang, et al.
Publicado: (2017)

Inhibition of miR-182-5p Targets FGF9 to Alleviate Osteoarthritis
por: Sun, Yang, et al.
Publicado: (2023)

miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer
por: Deng, Min, et al.
Publicado: (2013)

miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
por: Hiramoto, Hidekazu, et al.
Publicado: (2017)

MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer
por: Casanova-Salas, Irene, et al.
Publicado: (2015)

MicroRNA profiling in the dentate gyrus in epileptic rats: The role of miR-187-3p
por: Zhang, Suya, et al.
Publicado: (2017)

MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
por: Lin, Mao, et al.
Publicado: (2017)

Dysregulation of MiR-144-5p/RNF187 Axis Contributes To the Progression of Colorectal Cancer
por: Gao, Zhuo, et al.
Publicado: (2022)

HBx promotes hepatocellular carcinoma progression by repressing the transcription level of miR-187-5p
por: Deng, Yang, et al.
Publicado: (2023)

miR-187-5p Regulates Cell Growth and Apoptosis in Acute Lymphoblastic Leukemia via DKK2
por: Lou, Ye, et al.
Publicado: (2016)

Circular RNA-0001283 Suppresses Breast Cancer Proliferation and Invasion via MiR-187/HIPK3 Axis
por: Hu, Ying, et al.
Publicado: (2020)

MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating Integrin β1
por: Yang, Dejun, et al.
Publicado: (2019)

miR-187-3p inhibitor attenuates cerebral ischemia/reperfusion injury by regulating Seipin-mediated autophagic flux
por: Ren, Zhenkui, et al.
Publicado: (2020)

The decay of $^{187}$Pt: comparison of the levels of $^{187}$Ir
por: Sébille-Schück, C, et al.
Publicado: (1973)

Engineered exosomes for targeted delivery of miR-187-3p suppress the viability of hemangioma stem cells by targeting Notch signaling
por: Zhao, Ze-Liang, et al.
Publicado: (2022)

miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer
por: Wang, Hui, et al.
Publicado: (2017)

DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling: DSCR9/miR-21-5p/BTG2 regulates pancreatic cancer
por: Huang, Hui, et al.
Publicado: (2022)

Memorandum 187
por: CERN. Geneva. Proton Synchrotron and Synchrocyclotron Committee
Publicado: (1984)

MiR-18a regulates myoblasts proliferation by targeting Fgf1
por: Liu, Chuncheng, et al.
Publicado: (2018)

miR-29b, miR-205 and miR-221 Enhance Chemosensitivity to Gemcitabine in HuH28 Human Cholangiocarcinoma Cells
por: Okamoto, Kinya, et al.
Publicado: (2013)

MiR‐372‐3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma
por: Wang, Qing, et al.
Publicado: (2017)

Dysregulation of the circ_0087502/miR-1179/TGFBR2 pathway supports gemcitabine resistance in pancreatic cancer
por: Chen, Mingliu, et al.
Publicado: (2023)

Brg1 regulates murine liver regeneration by targeting miR‐187‐5p dependent on Hippo signalling pathway
por: Gong, Junhua, et al.
Publicado: (2020)

Lidocaine and Bupivacaine Downregulate MYB and DANCR lncRNA by Upregulating miR-187-5p in MCF-7 Cells
por: Lin, Chiao-Yi, et al.
Publicado: (2022)

Expression profiles of miRNAs in giant cell tumor of bone showed miR‐187‐5p and miR‐1323 can regulate biological functions through inhibiting FRS2
por: Jin, Yuanhan, et al.
Publicado: (2020)

miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction
por: Hu, Ying, et al.
Publicado: (2020)

Knockdown of long non-coding RNA NEAT1 relieves inflammation of ulcerative colitis by regulating the miR-603/FGF9 pathway
por: Li, Fengdong, et al.
Publicado: (2022)

miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells
por: Liu, Chunhui, et al.
Publicado: (2015)

miR‐149 controls non‐alcoholic fatty liver by targeting FGF‐21
por: Xiao, Junjie, et al.
Publicado: (2016)

Mesenchymal Stem/Stromal Cells Increase Cardiac miR-187-3p Expression in a Polymicrobial Animal Model of Sepsis
por: Ektesabi, Amin M., et al.
Publicado: (2021)

Measurements of the $(n,\gamma)$ and (n,n') reaction cross sections on $^{186,187,189}Os$ and $^{187}Re-^{187}Os$ cosmochronology
por: Segawa, M, et al.
Publicado: (2006)

FGF16 regulated by miR-520b enhances the cell proliferation of lung cancer
por: He, Wenfeng, et al.
Publicado: (2021)

miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation
por: Ma, Changpo, et al.
Publicado: (2019)

Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy
por: Marin-Muller, Christian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7jle0q2a8n3h40kp7srhob778b